Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ehrenstein

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|November 23, 2017
CD4 T-Cell Dysregulation in Psoriatic Arthritis Reveals a Regulatory Role for IL-22Amara Ezeonyeji, Helen Baldwin, Milica Vukmanovic-Stejic, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2008
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritisFabian Flores-Borja, Elizabeth C Jury, Claudia Mauri, et al.
Annals of the Rheumatic Diseases|November 20, 2013
B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritisLaetitia Rapetti, Konstantia-Maria Chavele, Catherine M Evans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosusElizabeth C Jury, David A Isenberg, Claudia Mauri, et al.
Clinical Rheumatology|October 26, 2010
Tuberculosis and anti-TNF treatment: experience of a central London hospitalSatveer Mankia, James E Peters, Swan Kang, et al.
Trials|July 18, 2020
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis planPatrick Muller, Kashfia Chowdhury, Caroline Gordon, et al.
Arthritis and Rheumatism|February 1, 2006
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritisMaria J Leandro, Geraldine Cambridge, Michael R Ehrenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Natural IgM is required for suppression of inflammatory arthritis by apoptotic cellsClare A Notley, Mark A Brown, Graham P Wright, et al.
European Journal of Immunology|December 15, 2004
Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitroPierre Quartier, Paul K Potter, Michael R Ehrenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 miceSarah Lawman, Claudia Mauri, Elizabeth C Jury, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|November 23, 2017
CD4 T-Cell Dysregulation in Psoriatic Arthritis Reveals a Regulatory Role for IL-22Amara Ezeonyeji, Helen Baldwin, Milica Vukmanovic-Stejic, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2008
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritisFabian Flores-Borja, Elizabeth C Jury, Claudia Mauri, et al.
Annals of the Rheumatic Diseases|November 20, 2013
B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritisLaetitia Rapetti, Konstantia-Maria Chavele, Catherine M Evans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosusElizabeth C Jury, David A Isenberg, Claudia Mauri, et al.
Clinical Rheumatology|October 26, 2010
Tuberculosis and anti-TNF treatment: experience of a central London hospitalSatveer Mankia, James E Peters, Swan Kang, et al.
Trials|July 18, 2020
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis planPatrick Muller, Kashfia Chowdhury, Caroline Gordon, et al.
Arthritis and Rheumatism|February 1, 2006
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritisMaria J Leandro, Geraldine Cambridge, Michael R Ehrenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Natural IgM is required for suppression of inflammatory arthritis by apoptotic cellsClare A Notley, Mark A Brown, Graham P Wright, et al.
European Journal of Immunology|December 15, 2004
Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitroPierre Quartier, Paul K Potter, Michael R Ehrenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 miceSarah Lawman, Claudia Mauri, Elizabeth C Jury, et al.
Pageof 7